Dogwood Therapeutics DWTX Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Dogwood Therapeutics's financing cash flow?
- Dogwood Therapeutics (DWTX) reported financing cash flow of $11.29M in Q1 2026.
- How has Dogwood Therapeutics's financing cash flow changed year-over-year?
- Dogwood Therapeutics's financing cash flow increased by 53.2% year-over-year, from $7.37M to $11.29M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.